Value of Physical Capacity Tests in Lung Cancer

Completed

• Conditions: Non Small Cell Lung Cancer; Small Cell Lung Cancer

• Registration Number: NCT01943578
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

The study examines the physical capacity of lung cancer patients assessed with the six minute walk test and handgrip strength. Demographic and selfreported exercise behavior is registered to explore correlations to functional and physical capacity.

Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-08-30
• Study Start: 2013-09
• Study First Submitted QC: 2013-09-16
• Study First Posted: 2013-09-17
• Primary Completion: 2014-06
• Study Completion: 2014-06
• Status Verified: 2014-11
• Last Update Submitted: 2014-11-04
• Last Update Posted: 2014-11-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Non small cell lung cancer stage I-IV
• Small cell lung cancer
• Patients >18 years
• WHO performance status 0-2
• undergoing chemotherapy

Exclusion Criteria

• unstable angina during the previous month
• myocardial infarction diagnosed within the last month
• not approval for physical activity by primary oncologist
• inability to provide informed consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality - Survival time	time from first chemotherapy treatment to death, assessed after 30 months	Prognostic value of the six minute walk and handgrip strength on mortality

Secondary Outcome Measures

Name	Time	Method
Self reported exercise behavior	before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.
Hand grip strength	before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.
Six minute walk test	Before first and after fourth chemotheraphy cycle, an expected average of 12 weeks between first and second assessment.

Trial Locations

Locations (1)

University Hospital of Copenhagen; 🇩🇰 Copenhagen, Denmark